White Paper

Engineering Controls Within HPAPI Manufacturing

Source: AbbVie

By Olindo Lazzaro, Director, Global EHS Technical Operations, & Max Brescia, Global Drug Product Account Director, AbbVie

As the demand in the global market for HPAPI drugs grows, so too is the expense of manufacturing HPAPIs due to the requirements for specialized facilities, additional PPE, medical surveillance for workers, pollution controls, and specialized housekeeping. As a result, more and more often the question pharmaceutical companies find themselves asking is, "Should we be searching for a CMO to manufacture our HPAPI?"

In this article, scientists from AbbVie Contract Manufacturing, a division of AbbVie, answer that question and discuss the strict regulations regarding the manufacture of HPAPIs and adherence to stringent guidelines to ensure that safety remains of paramount importance.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma